Our results showed that knockdown of PRMT1 expression or pharmacological inhibition of PRMT1 activity increased Annexin V+ cells, which suggests that PRMT1 inhibition may induce apoptosis in CML LSCs. This evidence concerns the gene PRMT1 and chronic myelogenous leukemia, BCR-ABL1 positive.